Telix Pharmaceuticals LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Telix Pharmaceuticals, an Australian biopharmaceutical company, is seeking to raise capital and expand its market presence with a proposed initial public offering on the Nasdaq Global Market.
NASDAQ
Telix Pharmaceuticals, an Australian radiopharmaceutical company, files for a US IPO to list on the Nasdaq Global Market under the symbol TLX.